Cargando…
Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is characterized by rapid progression, high recurrence rate and poor prognosis. Early prediction for the prognosis and immunotherapy efficacy is of great significance to improve the survival of HCC patients. However, there is still no reliable predictor at...
Autores principales: | Zeng, Zhili, Jiang, Xiao, Pan, Zhibin, Zhou, Ruisheng, Lin, Zhuangteng, Tang, Ying, Cui, Ying, Zhang, Enxin, Cao, Zebiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544325/ https://www.ncbi.nlm.nih.gov/pubmed/34607313 http://dx.doi.org/10.18632/aging.203574 |
Ejemplares similares
-
Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data
por: Zeng, Zhili, et al.
Publicado: (2021) -
Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data
por: Zeng, Zhili, et al.
Publicado: (2020) -
Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data
por: Zeng, Zhili, et al.
Publicado: (2020) -
Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma
por: Li, Xiaojin, et al.
Publicado: (2021) -
ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth
por: Li, Yongmei, et al.
Publicado: (2011)